Sun Pharmaceutical Industries Limited commits to U.S. medicines pricing and access agreements, extending MFN pricing to state Medicaid programs.
Sun Pharma reports Organon shareholder approval for acquisition, marking a significant step towards completing the merger transaction.
Sun Pharmaceutical Industries Limited (SUNPHARMA) announced approval to manufacture and market generic semaglutide in South Africa.
Sun Pharma to present long-term follow-up data on UNLOXCYT™ at ASCO 2026, showing nearly 27% complete response rate.
